{"schema_version":"secwatch.filing_event.v1","accession":"0001635088-26-000095","form_type":"8-K","ticker":"ROIV","cik":"0001635088","company_name":"Roivant Sciences Ltd.","filed_at":"2026-09-18T11:14:32+00:00","discovered_at":"2026-09-18T11:15:02.991327+00:00","generated_at":"2026-09-18T11:15:08.248738+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Roivant AGM: directors re-elected, EY ratified, say-on-pay passes with ~54% support","bullets":["Quorum of 652.1M shares (90.3% of 722.4M outstanding) present at Sept 16, 2026 AGM.","Daniel Gold (375.8M for) and Meghan FitzGerald (422.4M for) re-elected as Class II directors.","Ernst & Young ratified as FY2027 auditor with 651.3M votes for, 0.7M against.","Non-binding say-on-pay approved: 316.7M for vs 269.1M against (53.9% of votes cast)."],"urls":{"canonical":"https://secwatch.observer/filing/0001635088-26-000095","json":"https://secwatch.observer/filing/0001635088-26-000095.json","markdown":"https://secwatch.observer/filing/0001635088-26-000095.md","text":"https://secwatch.observer/filing/0001635088-26-000095.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635088/000163508826000095/0001635088-26-000095-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635088/000163508826000095/roiv-20260916.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-18T11:15:08.248738+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}